Department of Radiology, Affiliated Huai'an No 1 People's Hospital of Nanjing Medical University, Nanjing, China.
Contrast Media Mol Imaging. 2022 Jul 16;2022:7804015. doi: 10.1155/2022/7804015. eCollection 2022.
To evaluate the feasibility of reducing the injection velocity and volume of contrast agent according to BMI, and the effect of body weight (BW), body surface area(BSA), body mass index(BMI),and blood volume (BV) on aortic contrast enhancement when the voltage of third-generation dual-source CT is selected at 70 KV.
A total of 280 patients selected at 70 KV were randomly divided into an experimental group and a control group. Each group was divided into 7 subgroups according to BMI ≤20, 20-21, 21-22, 22-23, 23-24, 24-25, and 25-26. The experimental group uses 2.3/2.4/2.5/2.6/2.7/2.8/2.9 ml/s injection speed with 350 mgI/ml contrast agents according to the subgroups; injection time was fixed at 10 s. In the control group, the fixed injection flow rate was 3.5 ml/s, time was 12 s with a total of 42 ml. Subjects in both groups were inspected to adaptive prospective ECG-gating sequence scanning, and subjective and objective image quality of the two groups were compared using Student's -test. BMI, BSA, and BV were calculated from the patient's body weight and height. We assess the relationship between aortic attenuation and BW, BMI, BV, and BSA using regression analysis or correlation analysis.
Significant differences exist in vascular enhancement between the two groups; SNR and CNR of objective image quality in the experimental group were lower than those in the control group ( < 0.05). Both groups had the same subjective image scores ( > 0.05). The number of vessels in the optimal enhancement range counts more in the experimental group than in the control group (2 value = 334.25, < 0.05). In the control group, a weak to medium correlation was seen between vascular enhancement and BMI ( = -0.20), BW ( = -0.42), BSA ( = -0.46), and BV ( = -0.48) ( < 0.05 for all).
Compared to BW, BSA, and BV, a weaker negative correlation exists between vascular enhancement and BMI when ATVS selects 70 KV. However, as a much easier way to operate, the stepped low flow and low-contrast agent injection based on BMI was feasible, and the image quality was more homogenized than that of the control group.
评估根据 BMI 降低对比剂注射速度和体积的可行性,以及当第三代双源 CT 选择 70kV 时,体重(BW)、体表面积(BSA)、体重指数(BMI)和血容量(BV)对主动脉对比增强的影响。
选择 70kV 的 280 例患者随机分为实验组和对照组。根据 BMI≤20、20-21、21-22、22-23、23-24、24-25 和 25-26,将每组分为 7 个子组。实验组根据子组使用 2.3/2.4/2.5/2.6/2.7/2.8/2.9ml/s 的注射速度和 350mgI/ml 的对比剂;注射时间固定为 10s。在对照组中,固定注射流速为 3.5ml/s,时间为 12s,共 42ml。两组受试者均采用自适应前瞻性心电图门控序列扫描,采用 Student's-t 检验比较两组的主观和客观图像质量。从患者体重和身高计算 BMI、BSA 和 BV。使用回归分析或相关分析评估主动脉衰减与 BW、BMI、BV 和 BSA 的关系。
两组血管增强存在显著差异;实验组客观图像质量的 SNR 和 CNR 低于对照组( < 0.05)。两组的主观图像评分相同( > 0.05)。实验组最佳增强范围内的血管数量多于对照组(2 值=334.25, < 0.05)。在对照组中,血管增强与 BMI( = -0.20)、BW( = -0.42)、BSA( = -0.46)和 BV( = -0.48)呈弱至中度相关性(所有 < 0.05)。
与 BW、BSA 和 BV 相比,当 ATVS 选择 70kV 时,血管增强与 BMI 之间存在较弱的负相关。然而,作为一种更容易操作的方法,基于 BMI 的阶梯式低流速和低对比剂注射是可行的,并且图像质量比对照组更均匀。